TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.60nMAssay Description:Inhibition of human SLK using histone H3 as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by ra...More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 6.10nMAssay Description:Inhibition of SLK (unknown origin) by Off-chip Mobility Shift AssayMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 6.10nMAssay Description:Inhibition of N-terminal GST-tagged full length human SLK (1 to 1152 end residues) expressed in baculovirus expression system using fluorecence-label...More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 7.80nMAssay Description:Inhibition of SLK (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology methodMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 8.20nMAssay Description:Inhibition of SLK (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology methodMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of human SLK using Histone H3 as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 14.6nMAssay Description:Inhibition of human SLK using Histone H3 as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Inhibition of SLK (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology methodMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 43nMAssay Description:Inhibition of SLK (unknown origin)More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 47nMAssay Description:Inhibition of N-terminal GST-tagged full length human SLK (1 to 1152 end residues) expressed in baculovirus expression system using fluorecence-label...More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:Inhibition of recombinant full length GST-tagged human SLK expressed in baculovirus expression system by LanthaScreen assayMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 670nMAssay Description:Inhibition of human wild type SLK using RB-S6P as substrate preincubated for 2 hrs followed by ATP addition and measured every 2 mins for 2.5 hrs by ...More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 700nMAssay Description:Inhibition of NanoLuc-fused SLK (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assayMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 892nMAssay Description:Inhibition of human wild type partial length SLK (S14 to A307 residues) expressed in bacterial expression system by KINOMEscan analysisMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human SLKMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of NanoLuc-fused SLK (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assayMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of STK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma countingMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of SLK (unknown origin)More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of STLK2More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of SLK (unknown origin)More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant human SLK (1 to 373 residues) using RLGRDKYKTLRQI as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiom...More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of tracer 236 binding to recombinant full length human GST-tagged SLK expressed in baculovirus expression system measured after 60 mins by...More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human SLK using histone H3 as substrateMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of SLKMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.70E+4nMAssay Description:Inhibition of NanoLuc-fused SLK (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assayMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 1.90E+4nMAssay Description:Inhibition of NanoLuc-fused SLK (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assayMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of NanoLuc-fused SLK (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assayMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human SLK by discoverX kinome scan assayMore data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of SLK in human HeLa cells lysate pre incubated for 15 mins followed by ATP acyl phosphate probe addition and measured after 10 mins by LC...More data for this Ligand-Target Pair
TargetSTE20-like serine/threonine-protein kinase(Human)
Center for Lymphoid Malignancies
Curated by ChEMBL
Center for Lymphoid Malignancies
Curated by ChEMBL
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of SLK in human HeLa cells lysate pre incubated for 15 mins followed by ADP acyl phosphate probe addition and measured after 10 mins by LC...More data for this Ligand-Target Pair






















